To examine lipid management in a large national outpatient network, a cross-sectional study was conducted that included 1 385 242 active patients ages 20 to 79 years of age in a national network of over 5000 providers using electronic health records (EHRs). Adequate lipid testing, achievement of lipid goals, and appropriate use of lipid-lowering medication were defined according to National Cholesterol Education Program (NCEP) guidelines. Lipid testing was adequate for 62% of high-risk, 67% of moderate-risk, and 36% of low-risk patients. Lipid goals were achieved in 65%, 66%, and 90% of these 3 risk groups; 35%, 45%, and 32% achieved adequate testing and optimal goals. Medications were appropriately prescribed for 70%, 47%, and 48%. There is significant room for improvement in lipid management, particularly among high-risk patients. National EHR networks are excellent vehicles for large outpatient quality of care studies, particularly for measuring clinical outcomes such as lipid levels. (Am J Med Qual 2008;23:375-381)
Heart Protection StudyCollaborative Group.MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
2.
Shepherd J., Cobbe SM, Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995. Atheroscler Suppl. 2004;5:91-97.
3.
Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486-2497.
4.
Fox J., Jones K.Lipid-lowering interventions in managed care settings. Am J Med.2001;110:24S-30S.
5.
Olson KL, Bungard TJ, Tsuyuki RTCholesterol risk management: a systematic examination of the gap from evidence to practice. Pharmacotherapy. 2001 ;2:807-817.
6.
Gill JM, Mainous AG III, Diamond JJ, Lenhard MJImpact of provider continuity on quality of care for persons with diabetes mellitus. Ann Fam Med. 2003;1:162-170.
7.
McBride P., Schrott H., Plane MB, Underbakke G., Brown R.Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease. Arch Intern Med. 1998;158:1238-1244.
8.
Fuke D., Hunt J., Siemienczuk J., et al. Cholesterol management of patients with diabetes in a primary care practice-based research network. Am J Manag Care. 2004; 10:130-136.
9.
Thompson GR, O'Neill F., Seed M.Why some patients respond poorly to statins and how this might be remedied . Eur Heart J. 2002;23:200-206.
10.
Straka RJ, Taheri R., Cooper SL, Tan AW, Smith ACAssessment of hypercholesterolemia control in a managed care organization . Pharmacotherapy. 2001;21:818-827.
11.
Fonarow GC, Gawlinski A., Moughrabi S., Tillisch JHImproved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol. 2001;87:819-822.
12.
Pearson TA, Laurora I., Chu H., Kafonek S.The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 2000;160:459-467.
13.
Sueta CA, Chowdhury M., Boccuzzi SJ, et al. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1999;83:1303-1307.
14.
Gill JM, Fleischut P., Haas S., Pellini B., Al C., Nash DBUse of antibiotics for adult upper respiratory infections in outpatient settings: a national ambulatory network study. Fam Med. 2006;38:349-354.
15.
Gill JM, Foy AJ, Ling Y.Quality of outpatient care for diabetes mellitus in a national electronic health record network. Am J Med Qual. 2006 ;21:13-17.
16.
Logician [computer program]. Version 4.6. Hillsboro, OR : MedicaLogic/Medscape, Inc. ; 1994.
17.
Hunt D., Young P., Simes J., et al. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: results from the LIPID trial. Ann Intern Med. 2001;134:931-940.
18.
Cannon CP, Braunwald E., McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004 ;350:1495-1504.
19.
Grundy SM, Cleeman JI, Bairey CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation . 2004;110:227-239.
20.
American Diabetes Association.Standards of medical care in diabetes-2006. Diabetes Care . 2006;29:S4-S42.
21.
US Preventive Services Task Force.Guide to Clinical Preventive Services. 2nd ed. Baltimore, MD: Williams & Wilkins; 1996.
22.
Hulley SB, Newman TB, Grady D., Garber AM, Baron RB, Browner WSShould we be measuring blood cholesterol levels in young adults? JAMA. 1993;269:1416-1419.
23.
Prosser LA, Stinnett AA, Goldman PA, et al. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med. 2000; 132:769-779.
24.
Oderda G., Brixner D., Lieberman M.Comparison of EMR data to US National data. Paper presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 10th Annual European Congress; October 21, 2007; Dublin, Ireland.
25.
Maviglia SM , Teich JM, Fiskio J., Bates DWUsing an electronic medical record to identify opportunities to improve compliance with cholesterol guidelines. J Gen Intern Med. 2001;16:531-537.
26.
Mainous AG III, Koopman RJ, Diaz VA, Everett CJ, Wilson PW, Tilley BCA coronary heart disease risk score based on patient-reported information. Am J Cardiol. 2007;99:1236-1241.
27.
Camenga D., Gill JMTreatment of hypercholesterolemia in patients with diabetes at a family practice office. Del Med J. 2003;75:415-420.
28.
Gill JM, Ewen E., Nserko M.Impact of an electronic medical record on quality of care in a primary care office. Del Med J. 2001;73:187-194.
29.
Lobach DF, Hammond WEComputerized decision support based on a clinical practice guideline improves compliance with care standards. Am J Med. 1997;102:89-98.
30.
Wisdom K., Fryzek JP, Havstad SL, Anderson RM, Dreiling MC, Tilley BCComparison of laboratory test frequency and test results between African-Americans and Caucasians with diabetes: opportunity for improvement. Diabetes Care. 1997;20:971-977.
31.
Demakis JG, Beauchamp C., Cull WL, et al. Improving residents' compliance with standards of ambulatory care. JAMA. 2000;284:1411-1416.
32.
Kerr EA, Gerzoff RB, Krein SL, et al. Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med . 2004;141:272-281.
